Literature DB >> 9651151

Structure-activity relationship studies of novel carbocyclic influenza neuraminidase inhibitors.

C U Kim1, W Lew, M A Williams, H Wu, L Zhang, X Chen, P A Escarpe, D B Mendel, W G Laver, R C Stevens.   

Abstract

A series of influenza neuraminidase inhibitors with the cyclohexene scaffold containing lipophilic side chains have been synthesized and evaluated for influenza A and B neuraminidase inhibitory activity. The size and geometry of side chains have been modified systematically in order to investigate structure-activity relationships of this class of compounds. The X-ray crystal structures of several analogues complexed with neuraminidase revealed that the lipophilic side chains bound to the hydrophobic pocket consisted of Glu276, Ala246, Arg224, and Ile222 of the enzyme active site. The structure-activity relationship studies of this series have also demonstrated remarkably different inhibitory potency between influenza A and B neuraminidase. This indicated that the lipophilic side chains had quite different hydrophobic interactions with influenza A and B neuraminidase despite their complete homology in the active site. Influenza B neuraminidase appeared to be much more sensitive toward the increased steric bulkiness of inhibitors compared to influenza A neuraminidase. From the extensive structure-activity relationship investigation reported in this article, GS 4071 emerged as one of the most potent influenza neuraminidase inhibitors against both influenza A and B strains.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9651151     DOI: 10.1021/jm980162u

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  39 in total

1.  Analysis of inhibitor binding in influenza virus neuraminidase.

Authors:  B J Smith; P M Colman; M Von Itzstein; B Danylec; J N Varghese
Journal:  Protein Sci       Date:  2001-04       Impact factor: 6.725

2.  Target-induced formation of neuraminidase inhibitors from in vitro virtual combinatorial libraries.

Authors:  Matthias Hochgürtel; Heiko Kroth; Dorothea Piecha; Michael W Hofmann; Claude Nicolau; Sonja Krause; Otmar Schaaf; Gabriele Sonnenmoser; Alexey V Eliseev
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

3.  Discovery of Influenza A virus neuraminidase inhibitors using support vector machine and Naïve Bayesian models.

Authors:  Wenwen Lian; Jiansong Fang; Chao Li; Xiaocong Pang; Ai-Lin Liu; Guan-Hua Du
Journal:  Mol Divers       Date:  2015-12-21       Impact factor: 2.943

4.  Docking and 3D QSAR study of thiourea analogs as potent inhibitors of influenza virus neuraminidase.

Authors:  Jiaying Sun; Shaoxi Cai; Hu Mei; Jian Li; Ning Yan; Yuanqiang Wang
Journal:  J Mol Model       Date:  2010-03-07       Impact factor: 1.810

5.  Consensus QSAR model for identifying novel H5N1 inhibitors.

Authors:  Nitin Sharma; Chun Wei Yap
Journal:  Mol Divers       Date:  2012-07-21       Impact factor: 2.943

6.  Unique Determinants of Neuraminidase Inhibitor Resistance among N3, N7, and N9 Avian Influenza Viruses.

Authors:  Min-Suk Song; Bindumadhav M Marathe; Gyanendra Kumar; Sook-San Wong; Adam Rubrum; Mark Zanin; Young-Ki Choi; Robert G Webster; Elena A Govorkova; Richard J Webby
Journal:  J Virol       Date:  2015-08-19       Impact factor: 5.103

7.  Predicting dual-targeting anti-influenza agents using multi-models.

Authors:  Yu Wang; Hu Ge; Yali Li; Yufang Xie; Yingyan He; Mengyan Xu; Qiong Gu; Jun Xu
Journal:  Mol Divers       Date:  2014-10-02       Impact factor: 2.943

8.  Efficacy of novel hemagglutinin-neuraminidase inhibitors BCX 2798 and BCX 2855 against human parainfluenza viruses in vitro and in vivo.

Authors:  Irina V Alymova; Garry Taylor; Toru Takimoto; Tsu-Hsing Lin; Pooran Chand; Y Sudhakara Babu; Chenghong Li; Xiaoping Xiong; Allen Portner
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

9.  Characterization of human influenza virus variants selected in vitro in the presence of the neuraminidase inhibitor GS 4071.

Authors:  C Y Tai; P A Escarpe; R W Sidwell; M A Williams; W Lew; H Wu; C U Kim; D B Mendel
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

10.  A chemically programmed antibody is a long-lasting and potent inhibitor of influenza neuraminidase.

Authors:  Masahiko Hayakawa; Narihiro Toda; Nancy Carrillo; Natalie J Thornburg; James E Crowe; Carlos F Barbas
Journal:  Chembiochem       Date:  2012-09-10       Impact factor: 3.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.